Application
Dot blot analysis of anti-Phospho-ENT1(Slc29a1)-pS254 Antibody on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.| Product Name | Phospho-ENT1(Slc29a1)-pS254 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Modification | p-S254 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | DB |
| DB:0.388888888889 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | ENT1 |
|---|---|
| Alternative Names | SLC29A1 ENT1 Equilibrative nucleoside transporter 1 Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter Nucleoside transporter es-type Solute carrier family 29 member 1 |
| Molecular Weight(MW) | 50219 Da |
| Function | Mediates both influx and efflux of nucleosides across the membrane (equilibrative transporter). It is sensitive (ES) to low concentrations of the inhibitor nitrobenzylmercaptopurine riboside (NBMPR) and is sodium-independent. It has a higher affinity for adenosine. Inhibited by dipyridamole and dilazep (anticancer chemotherapeutics drugs) |
| Tissue Specificity | Expressed in heart, brain, mammary gland, erythrocytes and placenta, and also in fetal liver and spleen |
| Cellular Localization | Basolateral cell membrane; Multi-pass membrane protein. Apical cell membrane; Multi-pass membrane protein. Note=Predominantly localized in the basolateral membrane in polarized MDCK cells |
| Entrez Gene | 2030 |
|---|
Application
Dot blot analysis of anti-Phospho-ENT1(Slc29a1)-pS254 Antibody on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.| Application Notes | DB:0.388888888889 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step phosphospecific peptide affinity purification. |
